A Study to Assess the Mass Balance of [14C]HRS-8080 in Healthy Chinese Postmenopausal Female Subjects.

NCT07320521 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: [14C]HRS-8080

Sponsor

Shandong Suncadia Medicine Co., Ltd.